Editorial Team
Shanker Gupta, PhD, Editor-In-Chief
Dr. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years. Dr. Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Dr. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions. Dr. Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books.
Michael J. Sadowski, Managing Editor
Ghada Haddad, PhD, Associate Editor
Kurt Brorson, Phd, Associate Editor
JPST Editorial Board (JEB)
James Akers, PhD, Akers Kennedy & Associates
Jose Caraballo, MBA/ME, Kite Pharma, a Gilead Company
Dayue Chen, PhD, Genentech, a Member of the Roche Group
H. Gregg Claycamp, PhD, Consultant (U.S. FDA, retired)
Fenton Fong, MSc, xCellarate Technology Consulting Inc.
Kelvin Lee, PhD, NIIMBL
Duncan Low, PhD, Claymore Biopharm LLC
Tim Sandle, PhD, Bio Products Laboratory Limited
Alicja Sobantka, PhD, Octapharma
Edward C. Tidswell, PhD, Merck
Steve Zdravkovic, Baxter International Inc.
Qingyu Zeng, PhD, West Pharmaceutical Services, Inc.
Daniele Zuccato, MS, SCHOTT Pharma
Satish Singh, Moderna
Douglas Roepke, Eli Lilly and Company
Toni Manzano Doñabeitia, AIZON.ai
Alexander Stoll, Fresenius Kabi Production
Gerald McDonnell, Johnson & Johnson
Joanny Salvas, Pfizer
Anan Ben-David, 10AR – Sterile Engineering Solutions
Rebecca Walden, Irish Blood Transfusion Service
David Hubmayr, Takeda
Mario Stassen, Consultant
Noel Long, Cytiva
Jonathan Moore, Biopharmada
Walid El Azab, QP Pro Services
Antonio Burazer, Takeda
Tom Damratoski, Civica Rx
Richard Denk, Consultant
Jeremiah Genest, Just Evotec Biologics
Myriam Guest, Charles River Laboratories
Erika Pfeiler, ValSource, Inc.
Patrick Mains, ValSource, Inc.
Sandeep Kumar, Moderna
Dennis Jenke, Triad Scientific Solutions
Jean-Sebastien Steffen, Lonza AG
Darshana Patel, Merck & Co.rck
Lalit Saxena, Samsung BIologics
PDA, Inc., Leadership
Chair
Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Chair-elect
Melissa Seymour, Bristol Myers Squibb
Treasurer
Emma Ramnarine, PhD, Boehringer-Ingelheim
Secretary
Bettine Boltres, PhD, West Pharmaceutical Services
Immediate Past Chair
Susan Schniepp, Regulatory Compliance Associates Inc.
Directors
Cristiana Campa, PhD, GSK
Andrew Hopkins, Lachman Consultants
Ivy Louis, VIENNI Training & Consulting LLP
Amy McDaniel, PhD, Bristol Myers Squibb
Osamu Shirokizawa, Life Scienta Ltd.
PDA Staff Liaisons
Walter Morris, Sr. Director, Publishing & Press Relations
Whitney Alexis, Editorial Assistant